Abacavir sulfate is a potent HIV-specific agent frequently administered in the management of human immunodeficiency virus (HIV) infection. It exerts its therapeutic effect by competitively inhibiting the function of the viral reverse transcriptase enzyme, thereby preventing the conversion of HIV RNA to DNA. This blockade disrupts the viral replicat